These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9331070)

  • 1. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
    Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV
    Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene.
    Su GH; Hilgers W; Shekher MC; Tang DJ; Yeo CJ; Hruban RH; Kern SE
    Cancer Res; 1998 Jun; 58(11):2339-42. PubMed ID: 9622070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
    Yoshida BA; Dubauskas Z; Chekmareva MA; Christiano TR; Stadler WM; Rinker-Schaeffer CW
    Cancer Res; 1999 Nov; 59(21):5483-7. PubMed ID: 10554023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K; Shirasawa S; Nishioka M; Sasazuki T
    Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1.
    Widmann C; Johnson NL; Gardner AM; Smith RJ; Johnson GL
    Oncogene; 1997 Nov; 15(20):2439-47. PubMed ID: 9395240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma.
    Chae KS; Ryu BK; Lee MG; Byun DS; Chi SG
    Eur J Cancer; 2002 Oct; 38(15):2048-57. PubMed ID: 12376211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
    Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Calhoun ES; Falco G; Abdelmohsen K; Gorospe M; Kern SE
    Cancer Res; 2006 Jun; 66(11):5560-4. PubMed ID: 16740690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.
    Wang L; Pan Y; Dai JL
    Oncogene; 2004 Aug; 23(35):5978-85. PubMed ID: 15184866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression and activation of MAP kinase-activated protein kinase 2 in cardiac muscle cells.
    Zu YL; Ai Y; Gilchrist A; Maulik N; Watras J; Sha'afi RI; Das DK; Huang CK
    J Mol Cell Cardiol; 1997 Aug; 29(8):2159-68. PubMed ID: 9281447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired TCR-mediated apoptosis and Bcl-XL expression in T cells lacking the stress kinase activator SEK1/MKK4.
    Nishina H; Radvanyi L; Raju K; Sasaki T; Kozieradzki I; Penninger JM
    J Immunol; 1998 Oct; 161(7):3416-20. PubMed ID: 9759859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.
    Yamada SD; Hickson JA; Hrobowski Y; Vander Griend DJ; Benson D; Montag A; Karrison T; Huo D; Rutgers J; Adams S; Rinker-Schaeffer CW
    Cancer Res; 2002 Nov; 62(22):6717-23. PubMed ID: 12438272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.
    Kim HL; Vander Griend DJ; Yang X; Benson DA; Dubauskas Z; Yoshida BA; Chekmareva MA; Ichikawa Y; Sokoloff MH; Zhan P; Karrison T; Lin A; Stadler WM; Ichikawa T; Rubin MA; Rinker-Schaeffer CW
    Cancer Res; 2001 Apr; 61(7):2833-7. PubMed ID: 11306453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.
    Vander Griend DJ; Kocherginsky M; Hickson JA; Stadler WM; Lin A; Rinker-Schaeffer CW
    Cancer Res; 2005 Dec; 65(23):10984-91. PubMed ID: 16322247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of p38mapk, MKK3, and MKK4 by TNF-alpha in mouse bone marrow-derived macrophages.
    Winston BW; Chan ED; Johnson GL; Riches DW
    J Immunol; 1997 Nov; 159(9):4491-7. PubMed ID: 9379049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and cDNA cloning of SAPKK3, the major activator of RK/p38 in stress- and cytokine-stimulated monocytes and epithelial cells.
    Cuenda A; Alonso G; Morrice N; Jones M; Meier R; Cohen P; Nebreda AR
    EMBO J; 1996 Aug; 15(16):4156-64. PubMed ID: 8861944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the coding sequences of MEK-1 and MEK-2 genes in human lung cancer cell lines.
    Bansal A; Ramirez RD; Minna JD
    Oncogene; 1997 Mar; 14(10):1231-4. PubMed ID: 9121773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway.
    Atfi A; Prunier C; Mazars A; Défachelles AS; Cayre Y; Gespach C; Bourgeade MF
    Oncogene; 1999 Jul; 18(26):3878-85. PubMed ID: 10445851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways.
    Takekawa M; Posas F; Saito H
    EMBO J; 1997 Aug; 16(16):4973-82. PubMed ID: 9305639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development.
    Swat W; Fujikawa K; Ganiatsas S; Yang D; Xavier RJ; Harris NL; Davidson L; Ferrini R; Davis RJ; Labow MA; Flavell RA; Zon LI; Alt FW
    Immunity; 1998 May; 8(5):625-34. PubMed ID: 9620683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research.
    Robinson VL; Hickson JA; Vander Griend DJ; Dubauskas Z; Rinker-Schaeffer CW
    Clin Exp Metastasis; 2003; 20(1):25-30. PubMed ID: 12650604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.